1 The effects of a first dose and of chronic treatment with spirapril, a novel angiotensin converting enzyme (ACE) inhibitor, on short-term blood pressure and heart rate fluctuations were assessed by fast Fourier spectral analysis. The effects on systemic haemodynamics in supine and standing position were also studied. We treated 11 patients with 3 mg and 13 patients with 12 mg spirapril for 8 weeks. 2 Overall blood pressure variability was not changed by spirapril. By spectral analysis the changes in blood pressure and heart rate variability in various frequency bands can be assessed, which may be related to changes in activity of the autonomic nervous system. The relative power in the mid-frequency band (0.08-0.12 Hz) of supine systolic pressure was 23 + 10% during placebo and decreased during treatment with 1 2 mg to 11+4% (P<0.01 vs placebo, first dose) and to 13 ± 6% (P <0.01, chronic treatment). Standing systolic midfrequency power was 38 + 12% during placebo and decreased to 27 + 9% (PcO.Ol vs placebo) after the first dose of 12 mg, but it did not decrease after chronic treatment (29 ± 13%). Treatment with 3 mg induced no changes in mid-frequency blood pressure variability. A decrease in power of the mid-frequency band may point to a decrease in sympathetic vascular drive. The power in the high-frequency band (0.15-0.40 Hz) of heart rate did not change after treatment, suggesting that there is no change in the vagal cardiac drive. 3 Supine blood pressure decreased by a decrease in vascular resistance by (3 mg) and 14±19% (12 mg) after 8 weeks treatment. Heart rate, stroke volume and cardiac output did not change. No orthostatic hypotension occurred after the first dose. In the 12 mg group the orthostatic induced rise in heart rate (compared with supine) increased from +9±5 beats min" 1 (placebo) to +14±4 beats m in""1 (P<0.05) after the first dose. No changes in the orthostatic heart rate increase occurred in the 3 mg group. The orthostatic changes in stroke volume, cardiac output and vascular resistance were not influenced by spirapril. 4 In conclusion, the decrease in mid-frequency blood pressure variability may suggest an inhibitory effect of acute and chronic ACE inhibition upon sympathetic vasomotor control. Vagal activity was not influenced as highfrequency heart rate variability did not change. Acute and chronic ACE inhibition did not blunt important cardiovascular reflexes, as the haemodynamic response to orthostasis remained Meibergdreef 9, 1105 AZ Amsterdam,
Introduction
dosages (3 and 12 mg once daily) of spirapril on 24 h ambulatory blood pressure was studied in patients with Angiotensin converting enzyme (ACE) inhibitors are an mild to moderate essential hypertension [15] . All important class of drugs for the treatment of essential patients who participated in that study from our hypertension and congestive heart failure [1, 2] .
institutions also took part in the present study.
Although extensive investigations on their mechanisms
The study group comprised 30 patients, aged between of action have been performed, there are still some 20 and 60 years, all having essential hypertension. The unresolved questions. By inhibiting the angiotensin sitting diastolic blood pressure (Korotkoff phase V) of converting enzyme levels they decrease the levels of all patients was between 100 and 120mmHg (average circulating angiotensin II and aldosterone [1, 2] , thereby of three office readings) after a period of 4 weeks placebo inhibiting vasoconstriction and salt and water treatment. Secondary hypertension and overt target retention. ACE inhibitors also exert an influence on the organ damage were excluded by physical examination, autonomic nervous system [3, 4] which may contribute routine laboratory investigations, ECG and chest to their blood pressure lowering effect and could explain X-ray. All antihypertensive and other medications which the absence of reflex tachycardia. However, there is a might influence the cardiovascular system were disconvast body of conflicting data whether ACE inhibition tinued at the start of the placebo phase of the study, enhances parasympathetic activity without a concomi-Patients were instructed to refrain from changing their tant influence on sympathetic activity [5, 6] , or whether usual diet and level of physical activity and also to sympathetic activity is diminished by ACE inhibition abstain from using NSAIDs for the duration of the study. [7 -9 ] . An alternative explanation for the absence of Basic characteristics of all patients are listed in Table 1 . reflex tachycardia may be that ACE inhibitors increase No patients showed signs of left ventricular hypertrophy venous compliance, thereby reducing preload [1, 10] .
on the ECG. The protocol was drafted in accordance The aim of this study was to examine the effects of with the declaration of Helsinki (1989), approved by ACE inhibition on autonomic nervous function by the local hospital ethics committees and all subjects studying heart rate variations during forced breathing gave written informed consent. (which is a measure of vagal tone) and by studying blood pressure and heart rate variations by spectral analysis. Spectral analysis breaks down a signal to Study design its constituent frequency components, and quantifies the power of these components. Modulation of blood
The complete duration of the study was 12 weeks: 4 pressure and heart rate by baroreflex and sympathetic weeks placebo treatment was followed by an active and parasympathetic nervous activity has been shown treatment phase of 8 weeks during which patients were to be involved in the genesis of the various frequency treated with either 3 or 12 mg of spirapril in a doublecomponents of blood pressure and heart rate variability blind randomized fashion. Patients were instructed to [11] . We also studied the haemodynamic changes upon take one identical capsule every morning before breakstanding during ACE as these changes are fast at the same time. largely influenced by adjustments in vagal and sympath-During the study three measurement cycles were etic activity [12] . As ACE inhibitors can occasionally performed. The first after 4 weeks placebo treatment cause a pronounced drop in blood pressure after a first (baseline). The second measurement cycle was performed dose [13, 14] we examined the effects of both acute (first dose) and chronic treatment. We studied these effects in patients with essential mild to moderate hypertension by using the ACE inhibitor spirapril (TÏ 211-950, Sandoz, Basel, Switzerland) which is a new non- sulphhydryl ACE inhibitor. Spirapril itself is inactive, significant differences existed between the two groups but is rapidly de-esterified after absorption to its active diacid metabolite spiraprilat. Spirapril has been shown to be a potent blood pressure lowering agent with a long duration of action [15] .
Methods
This study was part of a larger multicentre study (4 centres) in which the efficacy and tolerability of two 3 mg(n =11) 12 4 h after the first active medication was taken, which calculated the power in two frequency bands: the midwas ingested immediately after the first measurement frequency band (0.08-0.12 Hz) and the high-frequency cycle (acute treatment, first dose). The third and also band (0.15-0.40 Hz). The power of these frequency bands last measurement cycle was performed after 8 weeks is considered to reflect sympathetic and vagal activity active treatment, again 4 h after ingestion of the active respectively [11, [20] [21] [22] . Total variance and percentual medication (chronic treatment). Blood samples were variance (power) of the mid-frequency and high-frequency taken on both measurement days prior to and 4 h after band of blood pressure and pulse interval in supine and ingestion of the medication for determination of plasma standing position were determined for the three different ACE concentrations by a colour kinetic assay. measurement cycles: the placebo phase (P), after the first dose (A) and after chronic treatment (C).
Measurements
Beat-to-beat noninvasive finger amics The signal analysis program a the beat-to-beat values of left ventricular stroke pressure was (SV), cardiac output (CO) and total peripheral resistance recorded by Finapres during all three above mentioned (TPR) using the pulse contour algorithm of Wesseling measurement cycles [16] [17] [18] . Every measurement cycle [23] . In short, SY is calculated from the aortic started with a test for forced respiratory sinus arrhythmia characteristic impedance and the arterial pressure wave-(FRSA) during which the patient was requested to form as the integral of the pressure pulse over the perform six maximal inspirations and expirations con-arterial systolic period [24,25], On comparison of CO secutively for 60 s. Thereafter the patient remained in by this method with thermodilution during changes in the supine position for 10 min. The patient was then blood pressure and heart rate in open heart surgery, a asked to stand up within 2 to 3 s and remain standing standard deviation of the difference between the two quietly for 5 min. A marker pulse identified the onset of methods of 10.6% (=0.541 min-1) was found [25]. To the inspirations during FRSA, as well as the onset of obtain absolute SV values, calibration with a standard the supine and standing periods. Care was taken to method such as thermodilution is needed, but without keep the hand, on which the finger blood pressure was such calibration the relative changes in SY can be used measured, at heart level (4th intercostal space in the [23, 24] . When comparing the pulse contour algorithm midaxillar line) during the complete measurement cycle applied to finger and intrabrachial arterial pressure to avoid hydrostatic errors. Finger blood pressure was waveforms [12] , we obtained almost identical results. measured at the same finger at all times.
We determined the absolute changes in mean arterial The manoeuvres were performed in the morning in a pressure (MAP) and heart rate (HR) and the relative room with a constant temperature of 22-24° C. All changes in SV, CO and TPR induced by acute and subjects abstained from coffee, tea and smoking starting chronic ACE inhibition after 10 min in the evening before the experiments. The continuous position compared with the placebo phase. Also, the blood pressure recording and the m arker pulse signal absolute and relative changes in were on line analogue-to-digital converted by a personal induced by standing were assessed. The values of all computer at 100 Hz per signal.
during the last minute of the supine position before up and the minute of [11, 20, 21] of supine and standing blood pressure and heart rate. The first minute of standing was omitted from the analysis as stabilization Results of blood pressure and heart rate takes some time. Integration of the curve for specific frequency-bands
Haemodynamic changes induced by ACE inhibition are yields variance for that particular frequency band. We summarized in Table 2 . Spirapril caused a reduction in 
Spectral analysis
Treatment with spirapril did not change overall variability of systolic blood pressure, both in the 3 mg group (supine variance: P : 79 ± 52; A : 92 ± 63; C : 7 3 ± 3 6 mmHg2, standing variance: P :5 8 ± 3 3 ; A: 79±42; C: 88 ±25 mmHg2) and the 12 mg group (supine variance: P : 54 ± 32; A : 47 ± 21; C : 53 ± 30 mmHg2, standing variance: P : 85 ± 47; A: 71 ±43; C:68±37 mmHg2). There were also no differences of overall variability of diastolic pressure and pulse interval, when comparing the placebo with the treatment periods.
In the placebo period there were no differences between the 3 and 12 mg groups in the relative power of the mid-frequency and high-frequency band of either systolic or diastolic pressure or pulse interval. Figure 1 shows that there were no changes in the power of the mid-frequency band after treatment with 3 mg spirapril. After the first dose of 12 mg spirapril, percentual power of the mid-frequency band decreased both in supine (from 23± 10 to 11 ±4% ; PcO.O l) and in standing position (from 38± 12 to 27±9% ; PcO.Ol). Mid-frequency power of systolic pressure decreased during chronic treatment with 12 mg of spirapril in supine position (1 3 ± 6 % , PcO.Ol) but not in standing position (29 + 13%, P>0.05). Power in the mid frequency band of diastolic pressure or pulse interval did not change in the 12 mg group. Power of the highfrequency band of pulse interval did not change after treatment with spirapril, either in supine or standing position, in the 3 or 12 mg group (Figure 1 ).
Orthostatic haemodynamics
The haemodynamic changes upon standing are summar ized in Figure 2 . Standing from supine induced an increase in H R and MAP. In the 12 mg group the increase in HR after the first dose, but not after chronic treatment, was significantly larger than in the placebo phase (placebo 9 ±5; first dose 14±4, P c0.05; chronic treatment 12± 6 beats m in "1, P>0.05). Increase in HR after standing in the 3 mg group was not different from the placebo phase. MAP also increased after standing from supine, treatment with either 3 or 12 mg spirapril did not change the magnitude of this increase both after the first dose or after 8 weeks treatment.
SV and CO generally decrease upon standing from supine. The increment in total peripheral resistance upon standing, proportionally larger than the decrease in CO, causes a rise in mean blood pressure. Acute or chronic treatment with spirapril did not influence the magnitude of the changes in SV, CO and TPR upon standing.
Discussion
The present analysis showed no difference in the blood pressure lowering effects of 3 and 12 mg spirapril ( Table 2 ) or in the decrease of plasma ACE levels. Blood pressure was decreased by a decrease in total peripheral resistance ( Table 2 ). Despite the spirapril induced vaso dilation, we found no reflex increase in stroke volume, cardiac output or heart rate. The haemodynamic profile of spirapril thus appears to be comparable with other pressor and a decreased blood pressure fall due to ACE inhibitors [1] , Since reflex cardio-stimulation by a-adrenergic receptor blockade after ACE inhibition, vasodilators may favour left ventricular hypertrophy and this was to indicate a decrease in [26] , the absence of a heart rate or stroke volume sympathictonus [8] . Although angiotensin II facilitates increase during treatment with ACE inhibitors may be noradrenaline release from terminal nerve endings [3] , considered as an important advantage from a clinical a number of studies reported no decrease in plasma point of view.
Numerous papers show an effect of ACE inhibitors on the autonomic nervous system, and this may at least partly explain the absence of reflex counter-regulatory reactions [1, 2] . However, there is no consensus whether catecholamines during treatment with an ACE inhibitor [6, 27, 28] . However, Philipp et al. [7] demonstrated a significant decrease in ACE inhibition. Several studies showed an increase in induced heart rate varu [27] or an increas ACE inhibition by studying pulse interval variability during forced respiration (FRSA) [19] , and by studying the variability of blood and interval bradycardia during the diving reflex [5, 28] after admin-in the mid-high-frequency bands by spectral istration of an ACE inhibitor. This was interpreted to analysis. Several factors influence the blood pressure represent an increased vagal tone. However, other and pulse interval spectra. Neural studies showed a smaller decrease in heart rate during considered to be the most important, and most of the facial immersion in water ('diving') [6, 29] . This last spectral components are probably generated by symfinding was also considered to express an increase in pathetic and parasympathetic nervous activity and the vagal tone through ACE inhibition. Thus, opposite baroreflex [11, [20] [21] [22] . Blood pressure variations which results are supposed to be caused by the same change cause baroreflex modulation of pulse interval by parain vagal activity. This suggests that no consensus on this topic is reached in the literature. sympathetic nerves affect both high-frequency and mid frequency powers, although mid-frequency power of Changes in sympathetic nervous system activity after pulse interval is also influenced by sympathetic nervous treatment with ACE inhibitors have also been studied activity due to the time delay of baroreflex action in the by studying cardiovascular responses to standardized mid-frequency range [11, 31] . Thus, the high-frequency manoeuvres.
In several studies no changes in the pulse interval variability may be considered to have the cardiovascular reactions to handgrip, mental stress or closest relation to vagal cardiac tone. Experiments with cold pressor have been reported [5, [28] [29] [30] . Another pharmacological vagal blockade corroborate this study reported a decreased tachycardia during cold notion [22, 32] , studying cardiovascular reflex responses is that spectral analysis may give an estimate of vagal and sympathetic activity during steady state circumstances, whilst the magnitude of vagally or sympathetically steered reflex responses may also be dependent on the unknown level of resting vagal or sympathetic tone.
We found no changes in the FRSA after acute and chronic treatment with spirapril Also, no changes in the power of the mid-and high-frequency band of heart rate were found in the present study. In the low dose group (3 mg) the power of the mid-frequency band of blood pressure did not change, but in the higher dosage group (12 mg) a decrease in systolic blood pressure variability in this frequency band was observed both after acute and chronic treatment with spirapril. Thus, no increment of vagal tone during ACE inhibition and no change in cardiac sympathetic tone was found. However, we did find a decrease of sympathetic ■ vasomotor tone during ACE inhibition in our patients by spectral analysis. This finding is in agreement with studies by Pagani et al. [37] and by Dutrey-Dupagne el al. [36] who also found a decrease of the mid frequency band of blood pressure variability after ACE inhibition. As discussed above plasma noradrenaline does not decrease, but the pressor response of the endorgan (peripheral blood vessels) to sympathetic stimula tion (noradrenaline) may be decreased after ACE inhibition [38, 39] . Thus, a sympatho-modulating effect of ACE inhibitors appears to be related to an effect on the neurotransmission at the postjunctional site, leading to diminished facilitation of noradrenergic stimuli rather than to a direct effect on the sympathetic nervous system itself.
Although an increase in 'overall' sympathetic nervous activity is considered to have unfavourable effects in hypertension [40] , the pathophysiological and clinical importance of sympathetic attenuation by ACE inhibi tors remains doubtful. Although we found a decrease in blood pressure and plasma ACE concentrations in the 3 mg group we did not find an effect on the sympathetic nervous system in that group. Also, the increase in There is much discussion on the origin of the blood vascular resistance by sympathetic activation upon pressure variability in the 0. blood pressure varie around this system, notwithstanding the large number of studies. frequency decreases after sino-aortic denervation, while
Occasionally, symptomatic hypotension is seen followtotal blood pressure variability increases (mainly by an ing a first dose of an ACE inhibitor [13, 14] , but in our increase in lower frequency variability) [33] , Moreover, patients the haemodynamic response to orthostasis there are theoretical arguments for the existence of a remained intact and nobody complained about dizziness 0.1 Hz resonance phenomenon in the feedback arterial upon standing. Although ACE inhibition causes arterial baroreceptor-sympathetic vasomotor loop [34] . Much vasodilatation, cardiac output does not increase after simplified, mid-frequency oscillations in blood pressure treatment with these drugs [1 ] , as was confirmed by may be the result of the delayed sympathetic vasomotor our results ( Table 2 ). This may be related to venous reaction on blood pressure changes sensed by the dilatation caused by ACE inhibitors, forearm venous baroreceptor and thus impose a specific rhythm on distensibility increases in response to administration of blood pressure [11, 21] . This explanation of mid-ACE inhibitors [41] , In our subjects the increase in frequency blood pressure variability is supported by heart rate upon standing was significantly larger after fact that it is diminished by pharmacological acute ACE inhibition in the 12 mg group. This may be a-adrenergic receptor blockade [22, 32] and when related to a more pronounced gravitational pooling of baroreflex sensitivity is decreased [35] .
blood due to an increase in venous compliance An advantage of this technique as compared with [10, 42, 43] , although we did not find significant A C E i * ! ♦ 55 differences in the decrease in stroke volume upon standing. An ACE inhibition-induced decrease in stroke volume and increase in heart rate during tilt was found by Ibsen et al. [44] . However, during lower body negative pressure the increase in heart rate did not change after ACE inhibition, and the decrease in forearm blood flow was even smaller [45, 46] . Thus, although there is some data to support the view that ACE inhibition increases venous compliance, as yet the evidence is far from conclusive. In conclusion, spirapril decreases blood pressure by decreasing total peripheral resistance, without causing an increase in heart rate, stroke volume or output. There are some indications for an inhibitory effect of acute and chronic ACE inhibition by spirapril upon sympathetic vasomotor control, while parasympa thetic cardiac drive was not influenced. The haemo dynamic response to orthostasis remained intact, and no clear evidence for a venodilatatory response was found in our subjects.
